A detailed history of Nbc Securities, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 2,303 shares of HALO stock, worth $108,609. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,303
Previous 3,124 26.28%
Holding current value
$108,609
Previous $163,000 19.63%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$51.3 - $64.42 $42,117 - $52,888
-821 Reduced 26.28%
2,303 $131,000
Q2 2024

Jul 10, 2024

BUY
$37.81 - $52.4 $71,914 - $99,664
1,902 Added 155.65%
3,124 $163,000
Q4 2023

Feb 07, 2024

SELL
$33.32 - $42.1 $5,197 - $6,567
-156 Reduced 11.32%
1,222 $45,000
Q3 2023

Nov 03, 2023

BUY
$36.46 - $44.03 $50,241 - $60,673
1,378 New
1,378 $52,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.